D.E. Shaw & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350M Buy
1,059,062
+614,569
+138% +$209M 0.28% 88
2025
Q4
$177M Buy
444,493
+245,076
+123% +$108M 0.13% 228
2025
Q3
$90.9M Buy
199,417
+91,141
+84% +$37.1M 0.07% 426
2025
Q2
$35.3M Sell
108,276
-181,586
-63% -$50.2M 0.04% 730
2025
Q1
$78.3M Sell
289,862
-73,223
-20% -$18.8M 0.09% 341
2024
Q4
$85.4M Buy
363,085
+30,780
+9% +$8.09M 0.09% 374
2024
Q3
$91.4M Buy
332,305
+52,907
+19% +$13.8M 0.12% 302
2024
Q2
$67.9M Buy
279,398
+176,011
+170% +$27.8M 0.1% 359
2024
Q1
$15.5M Buy
103,387
+7,843
+8% +$1.31M 0.02% 1087
2023
Q4
$18.3M Sell
95,544
-108,548
-53% -$18.5M 0.03% 989
2023
Q3
$36.1M Sell
204,092
-44,180
-18% -$8.43M 0.06% 556
2023
Q2
$47.2M Buy
248,272
+16,927
+7% +$3.36M 0.07% 457
2023
Q1
$46.3M Buy
231,345
+54,929
+31% +$11.5M 0.07% 450
2022
Q4
$41.9M Buy
176,416
+25,272
+17% +$5.39M 0.07% 506
2022
Q3
$30.3M Buy
151,144
+15,221
+11% +$2.9M 0.05% 624
2022
Q2
$19.8M Buy
135,923
+121,040
+813% +$17.2M 0.03% 876
2022
Q1
$2.43M Sell
14,883
-31,457
-68% -$4.79M ﹤0.01% 3122
2021
Q4
$7.86M Buy
46,340
+13,277
+40% +$2.47M 0.01% 1909
2021
Q3
$6.24M Sell
33,063
-3,345
-9% -$627K 0.01% 1899
2021
Q2
$6.17M Sell
36,408
-41,495
-53% -$6.08M 0.01% 1872
2021
Q1
$11M Buy
77,903
+13,402
+21% +$2.02M 0.01% 1289
2020
Q4
$8.38M Sell
64,501
-105,737
-62% -$14.1M 0.01% 1486
2020
Q3
$24.8M Buy
170,238
+56,351
+49% +$8.01M 0.03% 718
2020
Q2
$16.9M Sell
113,887
-116,666
-51% -$15.7M 0.03% 874
2020
Q1
$25.1M Buy
230,553
+211,925
+1,138% +$24.5M 0.05% 516
2019
Q4
$2.15M Sell
18,628
-8,169
-30% -$814K ﹤0.01% 2408
2019
Q3
$2.15M Buy
26,797
+13,040
+95% +$1.03M ﹤0.01% 2282
2019
Q2
$998K Buy
13,757
+2,543
+23% +$195K ﹤0.01% 2676
2019
Q1
$1.05M Sell
11,214
-25,604
-70% -$2.14M ﹤0.01% 2582
2018
Q4
$2.68M Buy
36,818
+28,080
+321% +$2.16M ﹤0.01% 1921
2018
Q3
$765K Sell
8,738
-74,873
-90% -$7.53M ﹤0.01% 2851
2018
Q2
$8.23M Sell
83,611
-187,450
-69% -$18.6M 0.01% 1210
2018
Q1
$32.3M Sell
271,061
-1,659
-0.6% -$214K 0.05% 483
2017
Q4
$34.6M Sell
272,720
-709,734
-72% -$89.2M 0.06% 456
2017
Q3
$115M Buy
982,454
+248,804
+34% +$21.2M 0.22% 131
2017
Q2
$58.5M Buy
733,650
+238,256
+48% +$15.2M 0.12% 257
2017
Q1
$25.4M Buy
495,394
+279,968
+130% +$12.9M 0.05% 482
2016
Q4
$8.06M Buy
215,426
+190,304
+758% +$7.97M 0.02% 1068
2016
Q3
$1.7M Sell
25,122
-14,630
-37% -$1.03M ﹤0.01% 2040
2016
Q2
$2.21M Sell
39,752
-155,292
-80% -$9.78M 0.01% 1866
2016
Q1
$12.2M Buy
195,044
+113,932
+140% +$7.57M 0.03% 753
2015
Q4
$7.64M Buy
81,112
+43,599
+116% +$4.04M 0.02% 1124
2015
Q3
$3.02M Sell
37,513
-166,514
-82% -$18.5M 0.01% 1774
2015
Q2
$24.5M Sell
204,027
-63,585
-24% -$7.6M 0.05% 558
2015
Q1
$27.9M Buy
267,612
+76,353
+40% +$7.74M 0.05% 493
2014
Q4
$18.6M Buy
191,259
+177,116
+1,252% +$16.4M 0.04% 751
2014
Q3
$1.1M Buy
14,143
+7,722
+120% +$498K ﹤0.01% 2712
2014
Q2
$406K Sell
6,421
-68,712
-91% -$4.08M ﹤0.01% 3676
2014
Q1
$5.04M Buy
75,133
+68,233
+989% +$5.28M 0.01% 1574
2013
Q4
$444K Buy
6,900
+3,601
+109% +$215K ﹤0.01% 3795
2013
Q3
$211K Sell
3,299
-215,789
-98% -$10.8M ﹤0.01% 4062
2013
Q2
$6.79M Buy
+219,088
New +$5.83M 0.02% 1140

Other funds holding ALNY